Tel Aviv, Israel · Founded 2021 · Privately Held (backing)
Operator of an artificial intelligence-based drug delivery company intended to facilitate lipid nanoparticle development for oligonucleotide therapies. Mana.bio is based in Tel Aviv, Israel and was founded in 2021. Its last reported valuation was $30.8 million in Oct 2023. It has raised $19.5 million.
Last reported valuation
$30.8M
Oct 2026
Priced at
—
Total raised
$19.5M
Last round
—
Team — not yet on record
No current team members for Mana.bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mana.bio with a free account
·Watch Mana.bio: the Monday email on marks, rounds and moves
